PT1079849E - Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica - Google Patents

Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica

Info

Publication number
PT1079849E
PT1079849E PT99926330T PT99926330T PT1079849E PT 1079849 E PT1079849 E PT 1079849E PT 99926330 T PT99926330 T PT 99926330T PT 99926330 T PT99926330 T PT 99926330T PT 1079849 E PT1079849 E PT 1079849E
Authority
PT
Portugal
Prior art keywords
medicines
preparation
cytotoxic activity
hmg proteins
hmg
Prior art date
Application number
PT99926330T
Other languages
English (en)
Inventor
Alberto Bartorelli
Original Assignee
Sicor Soc It Corticosteroidi S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Soc It Corticosteroidi S filed Critical Sicor Soc It Corticosteroidi S
Publication of PT1079849E publication Critical patent/PT1079849E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
PT99926330T 1998-05-19 1999-05-19 Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica PT1079849E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001094A IT1299583B1 (it) 1998-05-19 1998-05-19 Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica

Publications (1)

Publication Number Publication Date
PT1079849E true PT1079849E (pt) 2002-06-28

Family

ID=11380053

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99926330T PT1079849E (pt) 1998-05-19 1999-05-19 Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica

Country Status (10)

Country Link
EP (1) EP1079849B1 (pt)
JP (1) JP2002515445A (pt)
AT (1) ATE211391T1 (pt)
AU (1) AU4363199A (pt)
DE (1) DE69900756T2 (pt)
DK (1) DK1079849T3 (pt)
ES (1) ES2171086T3 (pt)
IT (1) IT1299583B1 (pt)
PT (1) PT1079849E (pt)
WO (1) WO1999059609A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151082B2 (en) 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US20020164644A1 (en) * 2000-04-05 2002-11-07 Ikuro Maruyama Adsorbents for high mobility group proteins and column for purifying body fluid
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
ITMI20011986A1 (it) * 2001-09-25 2003-03-25 San Raffaele Centro Fond Metodo e composizione per l'attivazione di cellule presentanti l'antigene
JP2005511770A (ja) * 2001-12-19 2005-04-28 アルケド バイオテック ゲーエムベーハー Ｈｍｇｂタンパク質およびｈｍｇｂタンパク質をコードする核酸の使用方法
GB0226251D0 (en) * 2002-11-11 2002-12-18 San Raffaele Centro Fond Acetylated protein
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
EP1668035A2 (en) 2003-09-11 2006-06-14 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
US8129130B2 (en) 2004-10-22 2012-03-06 The Feinstein Institute For Medical Research High affinity antibodies against HMGB1 and methods of use thereof
AU2005333602B2 (en) 2004-10-22 2012-04-12 Medimmune, Llc High affinity antibodies against HMGB1 and methods of use thereof
CA2631212A1 (en) 2005-11-28 2007-07-05 Medimmune, Llc Antagonists of hmgb1 and/or rage and methods of use thereof
DK2525817T3 (en) 2010-01-21 2017-10-02 Univ Arkansas Vaccine vectors and methods for enhancing immune responses
NZ702839A (en) 2010-06-09 2016-04-29 Univ Arkansas Vaccine and methods to reduce campylobacter infection
PT2956165T (pt) 2013-02-14 2019-11-29 Texas A & M Univ Sys Composições e métodos de potenciação das respostas imunitárias frente a eimeria ou limitação de uma infeção por eimeria
AU2014239557B2 (en) 2013-03-15 2019-01-03 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
JP7467027B2 (ja) 2016-05-03 2024-04-15 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー 免疫刺激性ポリペプチドおよび抗原性ポリペプチドを含む酵母ワクチンベクター並びにそれを使用する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62166897A (ja) * 1986-01-20 1987-07-23 Toyo Soda Mfg Co Ltd 核内非ヒストン蛋白質に対するモノクロ−ナル抗体
EP0727487A1 (en) * 1995-02-17 1996-08-21 K.U. Leuven Research & Development Multiple-tumor aberrant growth genes
FR2739292B1 (fr) * 1995-09-28 1997-10-31 Rhone Poulenc Rorer Sa Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
JP3018313B2 (ja) * 1996-02-23 2000-03-13 雪印乳業株式会社 骨形成促進及び骨吸収防止剤

Also Published As

Publication number Publication date
WO1999059609A2 (en) 1999-11-25
WO1999059609A3 (en) 2000-01-27
AU4363199A (en) 1999-12-06
DE69900756T2 (de) 2003-03-13
ATE211391T1 (de) 2002-01-15
ES2171086T3 (es) 2002-08-16
EP1079849A2 (en) 2001-03-07
EP1079849B1 (en) 2002-01-02
DE69900756D1 (de) 2002-02-28
DK1079849T3 (da) 2002-04-22
IT1299583B1 (it) 2000-03-16
JP2002515445A (ja) 2002-05-28
ITMI981094A1 (it) 1999-11-19

Similar Documents

Publication Publication Date Title
PT1079849E (pt) Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica
ATE254630T1 (de) Cyclosporine
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
PT97160A (pt) Processo para a preparacao de composicoes estaveis para administracao parenterica contendo uma proteina, peptideo ou polipeptideo biologicamente activo
PT848720E (pt) Antagonistas da actividade oncogenica da proteina mdm2 e sua utilizacao no tratamento de cancros
NO20010995D0 (no) Cytotoksiske peptider modifisert med store eller lipofile rester
ES2103857T3 (es) Peptidos ciclicos y su uso.
CA2280875A1 (en) Remedies for lymphocytic tumors
WO1999060013A3 (en) Il-6 antagonist peptides
ATE398630T1 (de) Zyklische conotoxin-peptide
HUP0002985A2 (hu) Glicirrizinsavat és legalább egy antivirális hatású proteint tartalmazó vírusellenes gyógyszerkészítmény
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
BR9810433A (pt) Composições anti-helmìnticas
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
PL355852A1 (en) Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients
NO20000424D0 (no) Streptograminer, deres fremstilling samt preparater inneholdende forbindelsene
ATE283279T1 (de) Therapeutische inhaltsstoffe
AU2001278884A1 (en) Anti-hiv and anti-tumor peptides and fragments of lysozyme
FI961505A0 (fi) Uudet veren koaguloitumisjärjestelmässä terapeuttisesti aktiiviset peptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
IL151211A0 (en) Compositions useful for regulating parkin gene activity
WO1998051295A1 (fr) Inhibiteur de la protease du vih-1, leur procede de production, et compositions medicinales
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок